These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 24505825)
21. Systemic radionuclide therapy of bone metastases with strontium-89. Porter AT; Davis LP Oncology (Williston Park); 1994 Feb; 8(2):93-6; discussion 96, 99-101. PubMed ID: 8167090 [TBL] [Abstract][Full Text] [Related]
22. Autopsy of a cadaver containing strontium-89-chloride. Schraml FV; Parr LF; Ghurani S; Silverman ED J Nucl Med; 1997 Mar; 38(3):380-2. PubMed ID: 9074523 [TBL] [Abstract][Full Text] [Related]
23. The Sr-89 bracelet. Amdur R; Eaton W; Mitchell S; Leopold K; Filimonov A Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):897. PubMed ID: 7790282 [No Abstract] [Full Text] [Related]
24. [Palliative treatment of bone metastasis with bone seeking radionuclides]. de Hooge P Ned Tijdschr Geneeskd; 1999 Jan; 143(4):224. PubMed ID: 10086148 [No Abstract] [Full Text] [Related]
25. [A case of multiple bony pain due to metastatic malignant pheochromocytoma successfully treated with strontium-89]. Takeshima T; Namura K; Sekiguchi Z; Takizawa A; Tsuchiya F; Iwasaki A; Ogi S Hinyokika Kiyo; 2014 Mar; 60(3):109-13. PubMed ID: 24759495 [TBL] [Abstract][Full Text] [Related]
26. [Radionuclide therapy for painful bone metastases]. Szefer J; Zuchora Z Wiad Lek; 2004; 57(5-6):280-3. PubMed ID: 15518077 [TBL] [Abstract][Full Text] [Related]
28. Tumoricidal effect of strontium-89. Yoshimura M; Saito K; Park J; Akata S; Koizumi K; Tokuue K; Kakizaki D Clin Nucl Med; 2011 Apr; 36(4):296-9. PubMed ID: 21368605 [No Abstract] [Full Text] [Related]
29. Experience with 89-strontium treatment of painful osseous metastases from breast cancer. Pizzocaro C; Panarotto MB; De Agostini A; Pagliaini R; Bestagno M Tumori; 1997; 83(2):558-9. PubMed ID: 9226020 [No Abstract] [Full Text] [Related]
30. Effective use of strontium-89 in osseous metastases. Kuroda I Ann Nucl Med; 2012 Apr; 26(3):197-206. PubMed ID: 22160737 [TBL] [Abstract][Full Text] [Related]
31. Strontium-89 for palliation of bone pain. Gompakis N; Triantafyllou P; Sidi B; Koliouskas ED; Salem N; Pistevou K Med Pediatr Oncol; 2003 Feb; 40(2):136. PubMed ID: 12461806 [No Abstract] [Full Text] [Related]
32. Question of the month--January 1995. What is the optimal dose of 89Sr for bone pain palliation? Khader Z Nucl Med Commun; 1995 Apr; 16(4):306. PubMed ID: 7542759 [No Abstract] [Full Text] [Related]
33. Strontium 89 therapy for the palliation of pain due to osseous metastases. Robinson RG; Preston DF; Schiefelbein M; Baxter KG JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352 [TBL] [Abstract][Full Text] [Related]
34. [2 years of experience with 89Sr therapy of multiple bone metastases (author's transl)]. Correns HJ; Mitterlechner E; Buchali K; Schnorr D; Seidel C; Mebel M Radiobiol Radiother (Berl); 1979 Jun; 20(3):360-2. PubMed ID: 515396 [No Abstract] [Full Text] [Related]
35. Hypocalcemia associated with strontium-89 administration in a patient with diffuse bone metastases from neuroendocrine carcinoma. Mori M; Fadul NA; Bruera E; Dalal S J Pain Symptom Manage; 2009 May; 37(5):923-9. PubMed ID: 19041217 [TBL] [Abstract][Full Text] [Related]
36. Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators Group. Bolger JJ; Dearnaley DP; Kirk D; Lewington VJ; Mason MD; Quilty PM; Reed NS; Russell JM; Yardley J Semin Oncol; 1993 Jun; 20(3 Suppl 2):32-3. PubMed ID: 7684863 [No Abstract] [Full Text] [Related]
38. Strontium-89 for treatment of painful bone metastasis from prostate cancer. Altman GB; Lee CA Oncol Nurs Forum; 1996 Apr; 23(3):523-7. PubMed ID: 8801513 [TBL] [Abstract][Full Text] [Related]
39. [Radiotherapy of bone metastases. A review of the literature]. Simon JM Bull Cancer Radiother; 1996; 83(4):290-8. PubMed ID: 9081330 [No Abstract] [Full Text] [Related]
40. New research developments increase therapeutic options for thyroid cancer and bone pain palliation. Williams JE J Nucl Med; 1997 Nov; 38(11):19N-20N, 26N. PubMed ID: 9374327 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]